Erratum: Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up (Leukemia (2012) 26, 2302; Doi:10.1038/leu.2012.175)

R. A. Larson, A. Hochhaus, T. P. Hughes, R. E. Clark, G. Etienne, D. W. Kim, I. W. Flinn, M. Kurokawa, B. Moiraghi, R. Yu, R. E. Blakesley, N. J. Gallagher, G. Saglio, H. M. Kantarjian

Research output: Contribution to journal › Comment/debate › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Erratum: Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up (Leukemia (2012) 26, 2302; Doi:10.1038/leu.2012.175)'. Together they form a unique fingerprint.